ID: ALA4067390

Max Phase: Preclinical

Molecular Formula: C12H17N3O2

Molecular Weight: 235.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(N2CCC2)nc(OC2CCC2)c1O

Standard InChI:  InChI=1S/C12H17N3O2/c1-8-10(16)11(17-9-4-2-5-9)14-12(13-8)15-6-3-7-15/h9,16H,2-7H2,1H3

Standard InChI Key:  MZNJBZANDDNNOC-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 235.29Molecular Weight (Monoisotopic): 235.1321AlogP: 1.63#Rotatable Bonds: 3
Polar Surface Area: 58.48Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.52CX Basic pKa: 5.39CX LogP: 1.90CX LogD: 1.89
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: -0.76

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source